Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saredutant in Generalized Anxiety Disorder
NCT00390650Phase 3Completed
- Sponsor
- Sanofi
- Start
- Oct 2006
- Primary completion
- Nov 2007
- Countries
- 2
01
Overview
A Phase 3 trial of saredutant in generalized anxiety disorder (GAD), sponsored by Sanofi. Started Oct 2006; status: completed.
02
Drugs
saredutant
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT00390650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00390650.